@article{TAU26958,
author = {Tilman Todenhöfer and Roland Seiler},
title = {Molecular subtypes and response to immunotherapy in bladder cancer patients},
journal = {Translational Andrology and Urology},
volume = {8},
number = {Suppl 3},
year = {2019},
keywords = {},
abstract = {The introduction of immunotherapy for the treatment of patients with advanced urothelial carcinoma has led to a significant interest in markers predicting therapy response. As in other tumor entities, approximately 20% of patients show objective response to single drug checkpoint inhibition. The identification of these patients is of great interest in order to avoid ineffective and expensive treatment.},
issn = {2223-4691}, url = {https://tau.amegroups.org/article/view/26958}
}